Better stability of acenocoumarol compared to warfarin treatment in one-year observational, clinical study in patients with nonvalvular atrial fibrillation

Medicinski Glasnik

Volumn 8, Issue 1, 2011, Pages 9-14

  Kulo, Aida ^a   Kusturica, Jasna ^a   Kapić, Elvedina ^a   Bečić, Fahir ^a   Rakanović Todić, Maida ^a   Burnazović Ristić, Lejla ^a   Mehmedović, Amila ^a   Lepara, Orhan ^a   Mulabegović, Nedžad ^a  

^a UNIVERSITY OF SARAJEVO   (Bosnia and Herzegovina)

Author keywords

Acenocoumarol; INR; Nonvalvular atrial fibrillation; Stability; Warfarin

Indexed keywords

ACENOCOUMAROL; ANTICOAGULANT AGENT; WARFARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; COMPARATIVE STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; NONVALVULAR ATRIAL FIBRILLATION; OBSERVATIONAL STUDY; PATIENT MONITORING; SCORING SYSTEM;

ACENOCOUMAROL; AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; WARFARIN;

EID: 79551716974     PISSN: 18400132     EISSN: 18402445     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Nutescu EA. American Society of Health-System Pharmacists. ASHP therapeutic position statement on antithrombotic therapy in chronic atrial fibrillation. Am J Health Syst Pharm 2007; 64:2281-91. (Pubitemid 350086194)
2. Ufer M. Comparative Pharmacokinetics of Vitamin K Antagonists Warfarin, Phenprocoumon and Acenocoumarol. Clin Pharmacokinet 2005; 44:1227-46.
3. Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 2008; 133:160S-198S.
4. Finkelstein J, Khare R, Ansell J. Feasibility and patients' acceptance of Home Automated Telemanagement of oral anticoagulation therapy. AMIA Annu Symp Proc 2003; 230-4.
5. Wong JE Are patients with cancer receiving adequate treatment for thrombosis? Results from FRONTLINE. Cancer Treat Rev 2003; 29:11-3.
6. Gadisseur AP, van der Meer FJ, Adriaansen HJ, Fihn SD, Rosendaal FR. Therapeutic quality control of oral anticoagulant therapy comparing the short-acting acenocoumarol and the long-acting phenprocoumon. Br J Haematol 2002; 117:940-6. (Pubitemid 34639259)
7. Hirsh J, Dalen JE, Anderson DR, Poller L, Bussey H, Ansell J, Deykin D, Brandt JT. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 1998; 114:445S-69S.
8. Gross CP, Vogel EW, Dhond AJ, Marple CB, Edwards R, Hauch O, Ezekowitz M. Factors influencing physicians' reported use of anticoagulant therapy in nonvalvular atrial fibrillation: a cross-sectional study. Clin Ther 2003; 25:1750-64. (Pubitemid 36801946)
9. Pattacini C, Manotti C, Pini M, Quintavalla R, Dettori AG. A comparative study on the quality of oral anticoagulant therapy (warfarin versus acenocoumarol). Thromb Haemost 1994; 71:188-91. (Pubitemid 24047324)
10. Amián A, Rodríguez JN, Muñiz R, Diéguez JC, Moreno MV, Quesada JA, Cañavate M, Fernández-Jurado A, Martino ML, Prados D. Comparative study of the stability of oral anticoagulant treatments (warfarin vs acenocoumarol). Sangre 1996; 41:9-11. (Pubitemid 26128201)
11. Kropacheva ES, Panchenko EP, Ataullakhanova DM. Long-term application of warfarin or acenocumarol in patients with fibrillating arrhythmia: the effects compared. Klin Med 2005; 83:24-7.
12. Palareti G, Legnani C, Guazzaloca G, Lelia V, Cosmi B, Lunghi B, Marchetti G, Poli D, Pengo V. Risks factors for highly unstable response to oral anticoagulation: a case-control study. Br J of Haematology 2005; 129:72-8. (Pubitemid 40524054)
13. Undas A, Cieśla-Dul M, Zółciński M, Tracz W. Switching from acenocoumarol to warfarin in patients with unstable anticoagulation and its effect on anticoagulation control. Pol Arch Med Wewn 2009; 119:360-5.
14. Barcellona D, Vannini ML, Fenu L Balestrieri C, Marongiu F. Warfarin or acenocoumarol: which is better in the management of oral anticoagulants? Thromb Haemost 1998; 80:899-902.
15. Laporte S, Quenet S, Buchmüller-Cordier A, Reynaud J, Tardy-Poncet B, Thirion C, Decousus H, Mismetti P. Compliance and stability of INR of two oral anticoagulants with different half-lives: a randomised trial. Thromb Haemost 2003; 89:458-67. (Pubitemid 36329235)
16. Lengyel M; SPORTIF-III Altanulmány Vizsgálói. Warfarin or acenocoumarol is better in the anticoagulant treatment of chronic atrial fibrillation? Orv Hetil 2004; 145:2619-21.
17. Berini OE, Alvarez PG, Onrubia AM. Comparison of quality and hemorragic risk of oral anticoagulant therapy using acenocoumarol versus warfarin. Med Clin 2008; 131:96-7. (Pubitemid 351930543)
18. Markatos CN, Grouzi E, Politou M, Gialeraki A, Merkouri E, Panagou I, Spiliotopoulou I, Travlou A.VKORC1 and CYP2C9 allelic variants influence acenocoumarol dose requirements in Greek patients. Pharmacogenomics 2008; 9:1631-8.
19. Wadelius M, Chen LY, Lindh JD, Eriksson N, Ghori MJ, Bumpstead S, Holm L, McGinnis R, Rane A, Deloukas P. The largest prospective warfarin-treated cohort supports genetic forecasting. Blood 2009; 113:784-92.
20. Ohno M, Yamamoto A, Ono A, Miura G, Funamoto M, Takemoto Y, Otsu K, Kouno Y, Tanabe T, Masunaga Y, Nonen S, Fujio Y, Azuma J. Influence of clinical and genetic factors on warfarin dose requirements among Japanese patients. Eur J Clin Pharmacol 2009; 65:1097-103.
21. Teichert M, Eijgelsheim M, Rivadeneira F, Uitterlinden AG, van Schaik RH, Hofman A, De Smet PA, van Gelder T, Visser LE, Stricker BH. A genome-wide association study of acenocoumarol maintenance dosage. Hum Mol Genet 2009; 18:3758-68.
22. Pasterkamp E, Kruithof CJ, Van der Meer FJM, Rosendaal FR, Vanderschoot JPM. A model-based algorithm for the monitoring of long-term anticoagulation therapy. J Thromb Haemost 2005; 3:915-21. (Pubitemid 41632819)
23. Singer DE, Albers GW, Dalen JE, Fang MC, Go AS, Halperin JL, Lip GY, Manning WJ. Antithrombotic Therapy in Atrial Fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 2008; 133:546-92.
24. Salem DN, O'Gara PT, Madias C, Pauker SG. Valvular and Structural Heart Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 2008; 133:593-629.
25. Gage BF, Yan Y, Milligan PE, Waterman AD, Culverhouse R, Rich MW, Radford MJ. Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF). Am Heart J 2006; 151:713-9. (Pubitemid 43290267)
26. Olson JD, Brandt JT, Chandler WL, Van Cott EM, Cunningham MT, Hayes TE, Kottke-Marchant K, Makur. RS, Uy AB, Wang EC. Laboratory reporting of the international normalized ratio: progress and problems. Arch Pathol Lab Med 2007; 131:1641-7. (Pubitemid 350077460)
27. Parra D, Beckey NP, Stevens GR. The effect of acetaminophen on the international normalized ratio in patients stabilized on warfarin therapy. Pharmacotherapy 2007; 27:675-83. (Pubitemid 46700959)
28. Benhamou Y, Le Cam-Duchez V, Schneller JM, Cailleux N, Magne JC, Soubrane JC, Borg JY, Lévesque H. Anticoagulation clinics for outpatients: a 5-year experience Rev Med Interne 2009; 30:567-72.
29. Ansell J, Hollowell J, Pengo V, Martinez-Brotons F, Caro J, Drouet L. Descriptive analysis of the process and quality of oral anticoagulation management in real-life practice in patients with chronic non-valvular atrial fibrillation: the international study of anticoagulation management (ISAM). J Thromb Thrombolysis 2007; 23:83-91. (Pubitemid 46416852)
30. Fihn SD, Gadisseur AA, Pasterkamp E, van der Meer FJ, Breukink-Engbers WG, Geven-Boere LM, van Meegen E, de Vries-Goldschmeding H, Antheunissen- Anneveld I, van't Hoff AR, Harderman D, Smink M, Rosendaal FR. Comparison of control and stability of oral anticoagulant therapy using acenocoumarol versus phenprocoumon. Thromb Haemost 2003; 90:260-6.
31. Jacobs LG. Warfarin pharmacology, clinical management, and evaluation of hemorrhagic risk for the elderly. Cardiol Clin 2008; 26:157-67. (Pubitemid 351491576)
32. Arnsten JH, Gelfand JM, Singer DE. Determinants of compliance with anticoagulation: a case-control study. Am J Med 1997; 103:11-7. (Pubitemid 27314182)
33. McCormick D, Gurwitz JH, Goldberg RJ, Becker R, Tate JP, Elwell A, Radford MJ. Prevalence and quality of warfarin use in patients with atrial fibrillation in the long-term care setting. Archives of Internal Medicine 2001; 16:12458-63.
34. Davis NJ, Billett HH, Cohen HW, Arnsten JH. Impact of adherence knowledge, and quality of life on anticoagulation control. Ann Phamacother 2005; 39:632-6. (Pubitemid 40396615)
35. van der Meer FJM, Briët E, Vandenbrouke JP, Srámek DI, Versluijs MHPM, Rosendaal FR. The role of compliance as a cause of instability in oral anticoagulant therapy. Br J Haematol 1997; 98:893-900. (Pubitemid 27421631)